ADGM

Adagio Medical Holdings, Inc.

There isn't enough reported data to score ADGM yet.

ADGM Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

ADGM's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

ADGM PE Valuation

ADGM has no meaningful PE right now: it lost money over the past year.

ADGM Forward outlook

MetricOutlook
--
Losses steady
--
--
Limited
High

Analysts expect ADGM's earnings, revenue and profitability to hold roughly steady.

ADGM Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $1.82 on Nov 12.

There is not enough scenario data to assess ADGM's risk to reward.

ADGM Earnings Per Share

Q3 2025: $-152.10
Q3 2025: $-152.10

ADGM Quarterly Revenue

Q3 2023: $41,000Q4 2023: $78,000Q1 2024: $26,000Q2 2024: --Q3 2024: $132,000Q4 2024: $137,000Q1 2025: --Q2 2025: --Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q3 2023: $41,000Q4 2023: $78,000Q1 2024: $26,000Q2 2024: --Q3 2024: $132,000Q4 2024: $137,000Q1 2025: --Q2 2025: --Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
QuarterRevenueYoY
Q4 2024$137K+76%
Q3 2024$132K+222%
Q1 2024$26K-57%

ADGM's revenue has slid since its 2024 peak: $0 last quarter, down 100% from the same quarter a year ago.

ADGM Free Cash Flow

Q3 2023: −$7MQ4 2023: −$7MQ1 2024: −$511,690Q2 2024: --Q3 2024: −$7MQ4 2024: −$8MQ1 2025: −$8MQ2 2025: −$5MQ3 2025: −$4MQ4 2025: −$4MQ1 2026: −$4MQ2 2026: −$5M
Q3 2023: −$7MQ4 2023: −$7MQ1 2024: −$511,690Q2 2024: --Q3 2024: −$7MQ4 2024: −$8MQ1 2025: −$8MQ2 2025: −$5MQ3 2025: −$4MQ4 2025: −$4MQ1 2026: −$4MQ2 2026: −$5M
QuarterFree cash flowYoY
Q2 2026-$5.3M-$600K
Q1 2026-$4.1M+$3.4M
Q4 2025-$3.6M+$4.2M
Q3 2025-$3.5M+$3.4M
Q1 2025-$7.5M-$7M
Q4 2024-$7.8M-$702K
Q3 2024-$6.9M-$419K
Q1 2024-$511.7K+$6M

ADGM has burned cash in almost every quarter: −$17M over the past year, against −$27M the year before.

ADGM Total Shares

Q3 2023: 446,255Q3 2024: 484,505Q4 2024: 495,556Q1 2025: 512,517Q2 2025: 512,719Q3 2025: 512,719Q1 2026: 740,349Q2 2026: 740,349
Q3 2023: 446,255Q3 2024: 484,505Q4 2024: 495,556Q1 2025: 512,517Q2 2025: 512,719Q3 2025: 512,719Q1 2026: 740,349Q2 2026: 740,349
PeriodChange %Net change
Quarterly0%--
1 year+44%+228K shares

ADGM has 740,349 diluted shares, up 44% from a year ago.

ADGM Net Leverage

ADGM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ADGM Weekly Momentum

MetricValueStatus
RSI26.1Oversold
Stochastic1.0Oversold

ADGM's weekly RSI is 26 (oversold) and its Stochastic is 1 (oversold).

ADGM PE vs Healthcare Sector

ADGM has no meaningful PE right now: it lost money over the past year.

ADGM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.3345% below
20 week MA$11.484% below
50 week MA$22.792% below
100 week MA$30.394% below

ADGM is in a downtrend: it's below all four of its weekly moving averages, and 94% below its 100-week average.

ADGM Yearly ROI

YearStart priceEnd priceROI
2024$245.1$31.5-87%
2025$31.5$31.2-1%
2026 YTD$31.2$1.82-94%

ADGM has finished every year since 2024 lower, and it's down 94% so far in 2026.

Give your agent the market.

Get API key